ClinicalTrials.Veeva

Menu

Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy

G

Germans Trias i Pujol Hospital

Status

Unknown

Conditions

Glaucoma

Treatments

Procedure: non-perforating deep sclerectomy surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04586738
Implants in deep sclerectomy

Details and patient eligibility

About

The aim of the study is to evaluate and compare the hypotensive efficacy at 24 months between non-perforating deep sclerectomy surgery with non-resorbable uveoscleral implant associated with absorbable collagen matrix versus non-perforating deep sclerectomy surgery with isolated absorbable collagen matrix implant.

Full description

The aim of this study is to evaluate and compare the hypotensive efficacy at 24 months between two implants in glaucoma surgery. Non-perforating deep sclerectomy surgery with non-resorbable uveoscleral implant associated with absorbable collagen matrix versus non-perforating deep sclerectomy surgery with isolated absorbable collagen matrix implant.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 18 years of age
  • Primary or secondary open-angle glaucoma
  • High intraocular pressure (greater than or equal to 18mmHg) despite using maximum medical treatment
  • Intolerance to medication.

Exclusion criteria

  • Patients with previous glaucoma surgery
  • Previous ocular surgery in the last 6 months
  • Previous history of Laser trabeculoplasty in the last 12 months
  • Moderate or severe diabetic retinopathy
  • Active or recurrent eye disease (uveitis)
  • Plateau iris
  • Ocular neovascularization
  • Aphakia
  • Neovascular angle-closure glaucoma
  • Previous history of intraocular or extraocular malignant neoplasm
  • Pregnancy or lactation period, axial length> 26mm and <20mm
  • Unwillingness for participating

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

120 participants in 2 patient groups

Non-resorbable uveoscleral implant associated with absorbable collagen matrix
Other group
Description:
non-perforating deep sclerectomy surgery with non-resorbable uveoscleral implant associated with absorbable collagen matrix
Treatment:
Procedure: non-perforating deep sclerectomy surgery
Isolated absorbable collagen matrix implant
Other group
Description:
non-perforating deep sclerectomy surgery with isolated absorbable collagen matrix implant
Treatment:
Procedure: non-perforating deep sclerectomy surgery

Trial contacts and locations

2

Loading...

Central trial contact

Jordi Loscos, MD; Jéssica Botella García, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems